Negative Pressure Wound Therapy for Skin Grafts
Clinical Randomized Controlled Trials on Negative Pressure Wound Therapy for Skin Grafts
1 other identifier
interventional
98
0 countries
N/A
Brief Summary
The repairing of various wounds is always a great challenge in burn surgery and plastic surgery. Skin-grafting is the main therapy. Bolster dressings are traditionally applied to secure the graft to the wound bed, however, there is some evidence to show that irregularly contoured recipient sites, poorly healing areas, reduce the success rate of skin-grafting with traditional bolster dressings, increasing morbidity, pain. Negative pressure wound therapy has been advocated as a potential solution to some of these issues. To further test the healing rate and safety of this new method, the investigators propose a prospective randomized controlled trial to compare this method with traditional bolster dressings application in skin-grafting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2015
Longer than P75 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 23, 2015
CompletedStudy Start
First participant enrolled
March 1, 2015
CompletedFirst Posted
Study publicly available on registry
March 2, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2018
CompletedFebruary 15, 2019
February 1, 2019
3.8 years
February 23, 2015
February 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
healing rate (the percentage of subjects that achieved complete wound closure, complete wound closure is defined as skin complete reepithelialization without drainage or dressing requirements)
the percentage of subjects that achieved complete wound closure, complete wound closure is defined as skin complete reepithelialization without drainage or dressing requirements.
postsurgery week 4
Secondary Outcomes (2)
VAS pain grade
postsurgery week 4
Skin graft survival rate
postsurgery week 2
Study Arms (2)
Negative pressure wound therapy
EXPERIMENTALNegative pressure wound therapy (NPWT) is the application of suction (negative pressure) to wounds with skin grafting.
standard pressure bolster dressing
ACTIVE COMPARATORThis method is traditional used in skin grafting wound.
Interventions
Negative pressure wound therapy (NPWT) is the application of suction (negative pressure) to wounds with skin grafting.
This method is traditional used in skin grafting wound.
Eligibility Criteria
You may qualify if:
- Subjects who need to skin graft to repair the wound
- Subjects signed the informed consent in the day of the age of not more than 85 years old (for minors, legal guardian should be signed)
- Stable vital signs, regular examination showed that subjects could tolerate surgery
- Subjects' mental state are good, could follow the doctor's advice, visit on a regular basis
- Understanding and willing to participate in this clinical trial and signed informed consent
- All women subjects must agree to take effective contraceptive measures in the six months study period, and without pregnancy before participate in the treatment
- No other serious diseases conflicts with the trail
You may not qualify if:
- Allergic constitution of negative pressure dressing
- Severe uncontrolled disease or acute systemic infections and complication with other serious heart, lung disease, encephalopathy and other organs or have a rapid progress or terminal disease
- Subjects with mental illness
- Subjects could not cooperate with the clinical trial personnel to finish trials
- Existing disease (malignant tumor, autoimmune disease) or require the use of drugs (high-dose glucocorticoids, which is defined as accepting 40 mg or more daily prednisone or prednisone amount, period of two weeks or more) will affect the healing of the wound
- For HIV positive patients, clinical diagnosis of patients with AIDS or the screening phase of neutrophil count (ANC) absolutely \< 1000 cells/mm3
- Subjects could not tolerate surgery
- Subjects are unlikely to survive in the study period
- The investigators think that who should not be included
- Subjects are in or participated in other clinical researchers over the past 12 weeks
- Subjects are participated in this trial at any time in the past
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Cao X, Hu Z, Zhang Y, Wang P, Huang S, Zhu W, Dong Y, Xu H, Tang B, Zhu J. Negative-Pressure Wound Therapy Improves Take Rate of Skin Graft in Irregular, High-Mobility Areas: A Randomized Controlled Trial. Plast Reconstr Surg. 2022 Dec 1;150(6):1341-1349. doi: 10.1097/PRS.0000000000009704. Epub 2022 Sep 27.
PMID: 36161796DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiayuan Zhu, Doctor
First Affiliated Hospital, Sun Yat-Sen University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, vice director of surgery
Study Record Dates
First Submitted
February 23, 2015
First Posted
March 2, 2015
Study Start
March 1, 2015
Primary Completion
December 1, 2018
Study Completion
December 1, 2018
Last Updated
February 15, 2019
Record last verified: 2019-02